These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 27718298)

  • 1. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.
    Diner I; Hales CM; Bishof I; Rabenold L; Duong DM; Yi H; Laur O; Gearing M; Troncoso J; Thambisetty M; Lah JJ; Levey AI; Seyfried NT
    J Biol Chem; 2014 Dec; 289(51):35296-313. PubMed ID: 25355317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
    Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
    Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
    Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
    Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
    Bai B; Hales CM; Chen PC; Gozal Y; Dammer EB; Fritz JJ; Wang X; Xia Q; Duong DM; Street C; Cantero G; Cheng D; Jones DR; Wu Z; Li Y; Diner I; Heilman CJ; Rees HD; Wu H; Lin L; Szulwach KE; Gearing M; Mufson EJ; Bennett DA; Montine TJ; Seyfried NT; Wingo TS; Sun YE; Jin P; Hanfelt J; Willcock DM; Levey A; Lah JJ; Peng J
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16562-7. PubMed ID: 24023061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.
    Bishof I; Dammer EB; Duong DM; Kundinger SR; Gearing M; Lah JJ; Levey AI; Seyfried NT
    J Biol Chem; 2018 Jul; 293(28):11047-11066. PubMed ID: 29802200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.
    Iacono D; Resnick SM; O'Brien R; Zonderman AB; An Y; Pletnikova O; Rudow G; Crain B; Troncoso JC
    J Neuropathol Exp Neurol; 2014 Apr; 73(4):295-304. PubMed ID: 24607960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer's disease.
    Jury-Garfe N; Redding-Ochoa J; You Y; Martínez P; Karahan H; Chimal-Juárez E; Johnson TS; Zhang J; Resnick S; Kim J; Troncoso JC; Lasagna-Reeves CA
    Acta Neuropathol; 2024 Aug; 148(1):15. PubMed ID: 39102080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.
    Diner I; Nguyen T; Seyfried NT
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Theoretical Analysis of the Synergy of Amyloid and Tau in Alzheimer's Disease.
    Han P; Shi J
    J Alzheimers Dis; 2016 Apr; 52(4):1461-70. PubMed ID: 27104897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease.
    Woltjer RL; Cimino PJ; Boutté AM; Schantz AM; Montine KS; Larson EB; Bird T; Quinn JF; Zhang J; Montine TJ
    FASEB J; 2005 Nov; 19(13):1923-5. PubMed ID: 16129700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.
    Tremblay C; François A; Delay C; Freland L; Vandal M; Bennett DA; Calon F
    J Neuropathol Exp Neurol; 2017 Feb; 76(2):70-88. PubMed ID: 28158844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
    Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
    Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Study of Aβ Oligomers in the Temporal Cortex and Cerebellum of Patients with Neuropathologically Confirmed Alzheimer's Disease Compared to Aged Controls.
    Savioz A; Giannakopoulos P; Herrmann FR; Klein WL; Kövari E; Bouras C; Giacobini E
    Neurodegener Dis; 2016; 16(5-6):398-406. PubMed ID: 27400224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic changes in Alzheimer's disease associated with progressive Aβ plaque and tau tangle pathologies.
    Pichet Binette A; Gaiteri C; Wennström M; Kumar A; Hristovska I; Spotorno N; Salvadó G; Strandberg O; Mathys H; Tsai LH; Palmqvist S; Mattsson-Carlgren N; Janelidze S; Stomrud E; Vogel JW; Hansson O
    Nat Neurosci; 2024 Oct; 27(10):1880-1891. PubMed ID: 39187705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
    Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
    Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.